{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-033539","form_type":"8-K","ticker":"KYNB","cik":"0000921299","company_name":"KYNTRA BIO, INC.","filed_at":"2025-02-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:06.816237+00:00","generated_at":"2026-05-26T06:42:17.482853+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"FibroGen enters ATM equity offering agreement for up to $30M with BofA Securities","bullets":["May sell up to $30M of common stock from time to time through BofA as sales agent.","BofA will receive a commission of up to 3.0% of gross sales proceeds.","Company is not obligated to sell any shares; offering may terminate upon sale of all shares or by agreement.","Shares sold under effective shelf registration (333-280597) and prospectus supplement dated Feb 24, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-033539","json":"https://secwatch.observer/filing/0001193125-25-033539.json","markdown":"https://secwatch.observer/filing/0001193125-25-033539.md","text":"https://secwatch.observer/filing/0001193125-25-033539.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/921299/000119312525033539/0001193125-25-033539-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/921299/000119312525033539/d921088d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T06:42:17.482853+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}